Clofibrate raises human 24 h intragastric acidity but does not affect plasma gastrin concentration.
Open Access
- 1 April 1990
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 29 (4) , 473-477
- https://doi.org/10.1111/j.1365-2125.1990.tb03666.x
Abstract
1. We studied the effects of acute oral dosing with clofibrate (500 mg four times daily) on 24 h intragastric acidity and plasma gastrin concentration in 12 healthy female subjects. 2. The 24 h integrated intragastric acidity rose from 429 mmol l‐1 h (95% CI 296‐479) before dosing to 527 mmol l‐1 h (95% CI 385‐664) on the day of dosing (+23%; P = 0.041), but no change was observed in the 24 h integrated plasma gastrin concentration: 420 pmol l‐1 h (95% CI 282‐499) before and 389 pmol l‐1 h (95% CI 249‐489) during dosing (P = 0.182). 3. We conclude that clofibrate has no acute antisecretory effect on the human stomach, and that human gastrin‐induced enterochromaffin‐like cell proliferation is unlikely with this drug.This publication has 13 references indexed in Scilit:
- Species variation in gastric toxicity following chronic administration of ciprofibrate to rat, mouse, and marmosetToxicology and Applied Pharmacology, 1988
- The effect of ciprofibrate on gastric secretion in the ratJournal of Pharmacy and Pharmacology, 1988
- Achlorhydria: hypergastrinaemia: carcinoids--a flawed hypothesis?Gut, 1987
- Gastric Neuroendocrine Cell Hyperplasia after Treatment with the Long-Acting, Potent H2-Receptor Antagonist SK&F 93479Scandinavian Journal of Gastroenterology, 1987
- Plasma gastrin and gastric enterochromaffinlike cell activation and proliferationGastroenterology, 1986
- Effect of Acid Inhibition on Gastric Endocrine CellsScandinavian Journal of Gastroenterology, 1986
- Alterations in Gastric Mucosal Morphology Induced by Long-Term Treatment with Omeprazole in RatsDigestion, 1986
- TUMORS IN MALE-RATS FED ETHYL CHLOROPHENOXYISOBUTYRATE, A HYPOLIPIDEMIC DRUG1979
- A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.Heart, 1978
- Clofibrate: antisecretory-antiulcer activity in the ratJournal of Pharmacy and Pharmacology, 1976